IPP Bureau

Maxivision appoints Surya K as Group Head – Medical Affairs and Quality
Maxivision appoints Surya K as Group Head – Medical Affairs and Quality

By IPP Bureau - May 23, 2026

Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.

Shreevar Kheruka appointed Managing Director at Borosil Limited
Shreevar Kheruka appointed Managing Director at Borosil Limited

By IPP Bureau - May 23, 2026

Kheruka has played a key role in transforming Borosil into a diversified, international consumer-focused enterprise

Fortis Healthcare  FY26 revenue crosses Rs. 9,100 crore
Fortis Healthcare FY26 revenue crosses Rs. 9,100 crore

By IPP Bureau - May 23, 2026

Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum

Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer
Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer

By IPP Bureau - May 23, 2026

The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments

Eli lilly’s retatrutide delivers up to 30% weight loss in phase 3 trial
Eli lilly’s retatrutide delivers up to 30% weight loss in phase 3 trial

By IPP Bureau - May 23, 2026

Clears major obesity endpoints at 80 weeks

Health ministry classifies Pregabalin under Schedule H1 to curb misuse
Health ministry classifies Pregabalin under Schedule H1 to curb misuse

By IPP Bureau - May 23, 2026

New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain

ZIM Laboratories wins European regulatory milestone with anticoagulant approval in Italy
ZIM Laboratories wins European regulatory milestone with anticoagulant approval in Italy

By IPP Bureau - May 23, 2026

The approval was granted by Agenzia Italiana del Farmaco

WACKER launches contract research services to accelerate next-gen RNA & DNA therapies
WACKER launches contract research services to accelerate next-gen RNA & DNA therapies

By IPP Bureau - May 23, 2026

The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich

Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr
Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr

By IPP Bureau - May 23, 2026

Transition to a fermentation-based globally integrated CDMO platform

ABDM crosses 100 crore ABHA-linked health records milestone
ABDM crosses 100 crore ABHA-linked health records milestone

By IPP Bureau - May 23, 2026

More than 450 public and private health technology solutions have integrated with the Ayushman Bharat Digital Mission ecosystem

OncoSil secures TGA approval for pancreatic cancer device
OncoSil secures TGA approval for pancreatic cancer device

By IPP Bureau - May 22, 2026

Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy

Eli Lilly appoints Chandan S. as Senior Director for Data Science and AI Engineering
Eli Lilly appoints Chandan S. as Senior Director for Data Science and AI Engineering

By IPP Bureau - May 22, 2026

AI and analytics leader brings extensive expertise in machine learning, GenAI, and life sciences decision intelligence to Lilly’s data science operations

Alembic Pharma elevates Karunanithi Ponnusamy as President of Animal Health Business
Alembic Pharma elevates Karunanithi Ponnusamy as President of Animal Health Business

By IPP Bureau - May 22, 2026

Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.

Reliance Life Sciences appoints Siva Sankar Mahamkali as VP Biosimilars Manufacturing Operations
Reliance Life Sciences appoints Siva Sankar Mahamkali as VP Biosimilars Manufacturing Operations

By IPP Bureau - May 22, 2026

Biologics manufacturing veteran brings over two decades of expertise in biosimilars, GMP operations, and large-scale biopharmaceutical manufacturing

Dr. Amit Arora joins Curelo as Co-founder & COO
Dr. Amit Arora joins Curelo as Co-founder & COO

By IPP Bureau - May 22, 2026

Diagnostic-guided healthcare platform strengthens leadership team to accelerate AI-driven diagnostics and consumer healthcare expansion

Latest Stories

Interviews

Packaging